Time course of regression of left ventricular hypertrophy in hypertensive patients treated with atenolol
作者:
FRANCIS DUNN,
HECTOR VENTURA,
FRANZtH MESSERLI,
ISAAC KOBRIN,
EDWARD FROHLICH,
期刊:
Circulation
(OVID Available online 1987)
卷期:
Volume 76,
issue 2
页码: 254-258
ISSN:0009-7322
年代: 1987
出版商: OVID
数据来源: OVID
摘要:
Regression of left ventricular hypertrophy occurs with a number of antihypertensive drugs, but the time course of this regression has not been defined clearly. We obtained echocardiograms at baseline and serially (on seven occasions) during a 1 year treatment period with the l3- adrenergic receptor inhibitor atenolol in 12 patients with previously untreated essential hypertension. To ensure control of blood pressure in all patients throughout the study, it was necessary to add a thiazide diuretic to the therapy of five patients. Baseline blood pressure was 155/100 mm Hg and fell to 136/84 mm Hg; there was a 20% reduction in heart rate. Posterior and septal wall thicknesses were reduced from 1.16 ± 0.03 to 1.06 ± 0.02 cm (p < .05) and from 1.28 + 0.07 to 1.18 ± 0.06 cm (p < .05), respectively; this reduction became significant initially at 4 weeks. Left ventricular mass decreased from 144 ± 9 to 127 + 7 g/m2 (p < .05) and this fall first became statistically significant at 6 months. Significant reduction in electrocardiographic voltages was also seen at 6 months. Therefore, regression of left ventricular hypertrophy with atenolol-induced blood pressure control occurred as early as 4 weeks after starting therapy and was maintained thereafter without apparent compromise of left ventricular systolic function.
点击下载:
PDF
(943KB)
返 回